These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
900 related articles for article (PubMed ID: 36333719)
1. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs. Gao Y; Ren J; Chen K; Guan G J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248 [TBL] [Abstract][Full Text] [Related]
3. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
4. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
5. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma. Zhou W; Zhang W BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models. Zhang P; Li H; Cheng X; Wang W Biomed Res Int; 2022; 2022():9139823. PubMed ID: 35872842 [TBL] [Abstract][Full Text] [Related]
7. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA. Han Y; Dong Z; Xing Y; Zhan Y; Zou J; Wang X BMC Pulm Med; 2023 Dec; 23(1):511. PubMed ID: 38102594 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
9. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
10. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487 [TBL] [Abstract][Full Text] [Related]
11. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL Front Genet; 2022; 13():930446. PubMed ID: 36110218 [No Abstract] [Full Text] [Related]
12. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma. Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y Front Oncol; 2022; 12():934928. PubMed ID: 35992788 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X Front Genet; 2022; 13():929035. PubMed ID: 36081998 [No Abstract] [Full Text] [Related]
14. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Yang C; Zhang L; Hao X; Tang M; Zhou B; Hou J Curr Oncol; 2022 Dec; 30(1):430-448. PubMed ID: 36661684 [TBL] [Abstract][Full Text] [Related]
15. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma. Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136 [TBL] [Abstract][Full Text] [Related]
16. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma. Wang W; Cui G; Zhao S Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013 [TBL] [Abstract][Full Text] [Related]
17. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma. Zhang C; Zhou D; Wang Z; Ju Z; He J; Zhao G; Wang R Front Genet; 2022; 13():907754. PubMed ID: 35754819 [TBL] [Abstract][Full Text] [Related]
18. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
19. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer. Li Z; Zhao J; Huang X; Wang J Sci Rep; 2023 Mar; 13(1):4302. PubMed ID: 36922569 [TBL] [Abstract][Full Text] [Related]
20. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network. Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]